Corneal pharmacokinetics of the 2% diacerein eye drops between multiple administration and single administration
Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 4
Abstract
AIM: To compare the pharmacokinetic differences of the 2% diacerein eye drops between conjunctival sac multiple administration and single administration in the cornea, and to provide the experimental basis for clinicians to use the conjunctival sac multiple administration.<p>METHODS: Male Kunming mice were randomly divided into the multiple administration group and the single administration group. The multiple administration group were given diacerein eye drop every 2min(3 times in total). The concentrations of the metabolites of diacerein in the cornea were measured by high performance liquid chromatography after given eye drop 5, 15, 30, 60, 120, and 180min. The pharmacokinetic parameters were calculated by pharmacokinetic software(DAS2.1.1). <p>RESULTS: The metabolites of diacerein, rhein, was detected in the cornea at each time point. The concentration of the metabolite of diacerein in the cornea was 318.678±40.88, 210.02±25.66, 188.83±31.74, 112.24±11.70, 90.28±22.01 and 57.67±13.71μg/g after given eye drop 5, 15, 30, 60, 120, and 180min in the multiple administration group. The concentration in the single administration group was 145.17±19.29, 97.95±10.49, 71.18±18.70, 39.11±2.44, 18.10±2.34 and 9.08±2.04μg/g respectively. The concentration of rhein in the cornea was the highest at 5min after the administration in the two groups. The concentration of the multiple administration group was higher than that in the single administration group at 5, 15, 30, 60, 120, and 180min(<i>P</i><0.01). The half-life of the drug was 0.89±0.31h in the single administration group. <p>CONCLUSION: Compared with the single administration, the conjunctival sac multiple administration has the advantages of high drug concentration and long duration. Therefor the conjunctival sac multiple administration is a more effective method to treat acute infectious corneal diseases.
Authors and Affiliations
Hong-Min Zhang
Keywords
Related Articles
- EP ID EP656091
- DOI 10.3980/j.issn.1672-5123.2018.4.08
- Views 124
- Downloads 0
Early detection using dual-specific probe technique for genetic mutation of congenital cataract lens protein
AIM: To screen congenital cataract in the early stage using dual-specific probe technique composed of DNA hybridization and chromogenic probe. <p>METHODS: The mRNA was isolated from venous blood of 14 congenital cataract...
Effects of intravitreal injection Conbercept combined with 23G minimally invasive vitrectomy on PDR
AIM: To explore the effect of intravitreal injection of Conbercept combined with 23G minimally invasive vitrectomy on retinal hemorrhage, retinal proliferation and visual prognosis in patients with proliferative diabetic...
Progress on treatment of anterior ischemic optic neuropathy
Anterior ischemic optic neuropathy( AION )is the most common acute optic neuropathy in people over 50 years old, which often causes unilateral acute painless visual loss. Non-arteritis anterior ischemic optic neuropathy(...
Correlative analysis of eccentricity of optical treatment zone with tear film function and corneal shape after wearing orthokeratology lenses
AIM: To explore the correlation between eccentricity in the optical treatment area and tear film function and corneal morphology after orthokeratology. <p>METHODS:Eighty patients(80 eyes)with myopia who were treated with...
Progress on the visual dysfunction after Alzheimer's disease and its mechanism
Alzheimer's disease(AD)is a neurodegenerative disease and is the most common type of dementia. It impairs the quality of life of a person and their family, posing a serious economic and social threat in developed countri...